Document Details

Form
Filing Date
Feb 17, 2023
Document Date
Feb 16, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Keros Therapeutics
Issuer
Keros Therapeutics, Inc.
Filer
Regnante Keith

Investor Contact